Galmed Pharmaceuticals
GLMD
GLMD
34 hedge funds and large institutions have $60.6M invested in Galmed Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $111K
Holders
34
Holding in Top 10
1
Calls
–
Puts
$111K
Top Buyers
| 1 | +$1.3M | |
| 2 | +$284K | |
| 3 | +$173K | |
| 4 |
Goldman Sachs
New York
|
+$138K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$106K |
Top Sellers
| 1 | -$726K | |
| 2 | -$507K | |
| 3 | -$505K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$325K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$300K |